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Abstract
Actinomycetes (Actinobacteria) are highly attractive as cell factories or bioreactors for applications
in industrial, agricultural, environmental, and pharmaceutical fields. Genome sequencing of several
species of actinomycetes has paved the way for biochemical and structural analysis of important
proteins and the production of such proteins as recombinants on a commercial scale. In this regard,
there is a need for improved expression vectors that will be applicable to actinomycetes. Recent
advancements in gene expression systems, knowledge regarding the intracellular environment, and
identification and characterization of plasmids has made it possible to develop practicable
recombinant expression systems in actinomycetes as described in this review.
Review
As a result of the sequencing of entire genomes of more
than 100 organisms, the number of open reading frames
with unknown functions has increased. To characterize
such proteins biochemically and structurally, it is impor-
tant to obtain substantial amounts of recombinant pro-
teins. Escherichia coli, a Gram-negative γ -proteobacterium,
is the most commonly used host bacterium for the large-
scale production of recombinant proteins. However, the
expression and isolation of all the proteins in E. coli is dif-
ficult on account of the problems of insolubility, cytotox-
icity, post-translational modifications, or inefficient
translation.
In order to overcome these problems, host-vector systems
other than E. coli have also been developed in both
prokaryotic and eukaryotic cells. Bacillus  spp. (e.g., B.
brevis and B. subtilis) and Lactococcus lactis are Gram-posi-
tive bacteria with low G + C content and are often used to
secrete expressed proteins into the culture media [1-5].
Secretion prevents the local accumulation of the recom-
binant proteins and this occasionally aids in correct pro-
tein folding [6]. Bacillus brevis has an extremely high
capacity of protein secretion and is being used for the
expression of prokaryotic and eukaryotic proteins on an
industrial scale [2]. Lactococcus lactis can also be used for
the secretion of recombinant proteins and these proteins
can be used directly in food applications [5]. Eukaryotic
cells such as yeast cells, insect cells, or immortalized cell
lines are particularly useful for the expression of proteins
that undergo post-translational modifications [7].
In actinomycetes (Gram-positive bacteria with a high G +
C content), the genera Streptomyces, Rhodococcus, Coryne-
bacterium, and Mycobacterim have received an increasing
amount of attention, particularly in the industrial fields.
They exhibit potential advantages in the synthesis of sec-
ondary metabolites of industrial and medical importance,
in the production of amino acids by fermentation, and in
bioconversion processes. There have also been several
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host-vector systems developed for actinomycetes [8,9],
although further improvements were needed to provide
highly inducible and tightly regulated promoters, broad-
host range vectors, and high producibility of recombinant
proteins. Recently, improvements in the host-vector sys-
tems in this class of bacteria were reported, thereby mak-
ing it possible to obtain significant amounts of
recombinant proteins under strictly regulated promoters
[10-12]. Here, we review the host-vector systems, particu-
larly expression vectors, in actinomycetes and also
describe the benefits and future possibilities of the system.
Why actinomycetes?
We can highlight two striking characteristics of actinomyc-
etes as host cells. First, they exhibit a unique metabolic
diversity and enzymatic capabilities. The compounds they
produce as secondary metabolites are valuable for indus-
trial and pharmaceutical purposes [13], and the enzymes
themselves are also valuable. For example, Streptomyces
spp. produce various types of antibiotics [14] and some
Rhodococcus spp. are being used for the industrial produc-
tion of acrylamide [15]. Historically, the host-vector sys-
tems in actinomycetes have been developed to obtain
such enzymes in large quantities and/or to manipulate the
metabolic pathway involved in the production of antibi-
otics [8,9]. Second, actinomycetes are expected to have
different intracellular milieu as compared to conventional
host cells such as E. coli. Until recently, no host cell from
which all the proteins can be universally expressed in large
quantities has been found. Therefore, it is important to
provide a variety of host-vector systems (expression sys-
tems) in order to increase the opportunities to screen for
the most suitable expression conditions or host cell.
It is important to select an appropriate promoter for high-
level protein expression, and generally, an inducible pro-
moter is more preferable than a constitutive promoter
[8,10]. Several reports used well characterized promoters
of the nitrilase gene [10], acetoamidase gene [16], and
tipA [11,12,17]. In S. coelicolor, the expression vector con-
taining actI/actIII promoter was induced during the transi-
tion from the growth to the stationary phase to
successfully produce polyketido synthases [18]. A deriva-
tive of this vector can be used with other actinomycetes
[19], thereby expanding the application of the expression
system. In M. smegmatis, novel strong constitutive pro-
moters were identified using a genomic library fused to
promoterless green fluorescent protein in combination
with a fluorescence-associated cell sorting technique [20].
On the other hand, the mutagenesis of the repressor gene
is another possible strategy in which the constitutively
expressed temperature-sensitive repressor protein is una-
ble to repress the target gene expression at a high temper-
ature [21,22]. In this review, we have focused on the
systems using heterologous promoters to drive strong
expression and some examples of such vectors of actino-
mycetes are summarized in Table 1. In the next sections,
several recent topics are discussed in detail.
Table 1: Expression vectors in actinomycetes
Vectors Inducers Location Comments Ref.
Streptomyces
pSH19 ε -caprolactam cytoplasm high-level expression [10]
pULHis2 thiostrepton cytoplasm [17]
pRM5 - cytoplasm growth phase-dependent expression [18]
pITS-vectors -(constitutive) cytoplasm [21]
pLTI-CD4 -(constitutive) secretion >300 mg l-1 production of CD4 [27]
pSJ205∆ EcA -(constitutive) secretion [28]
pLMS-vectors -(constitutive) secretion [29]
Rhodococcus
pTip-vectors thiostrepton cytoplasm expression at low temperatures [11,1
2]
pNit-vectors -(constitutive) cytoplasm constitutive type of pTip-vectors [12]
pNT -(constitutive) cytoplasm [37]
Mycobacterium
pJAM2 acetoamide cytoplasm [16]
pJEX77 -(constitutive) cytoplasm [20]
pJEM15-traRts107-Ptra high temperature cytoplasm expression level is not high [22]
Corynebacterium
pECTAC-K99 -(constitutive) cytoplasm [36]
pCGL-vectors -(constitutive) secretion [38]
pWLQ-vectors IPTG cytoplasm or secretion [39]Microbial Cell Factories 2005, 4:7 http://www.microbialcellfactories.com/content/4/1/7
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Streptomyces species
Among the Streptomyces spp., S. lividans has been exten-
sively utilized as a potential host for both cytoplasmic and
secreted protein production because it lacks restriction
systems that are generally present in other Streptomyces
and prevent the genetic manipulation of host cells [23]. In
addition, S. lividans also exhibits a very low endogenous
extracellular proteolytic activity [23].
Recently, Herai et al. reported an expression vector that
functions in several Streptomyces spp. [10]. The vector car-
ries the nitrilase gene promoter (PnitA) originating from
the nocardioform actinomycete Rhodococcus rhodochrous
J1 [15]. The expression is tightly regulated and strongly
induced only in the presence of the inducer ε -caprol-
actam. These researchers expressed several bacterial genes
and estimated that up to ~40% of all soluble protein com-
prised a target protein and that up to 396 mg of the pro-
tein per liter of culture media was produced (e.g., the
Streptomyces  inducible expression system had thus far
expressed a maximum of 38 mg of the protein per liter of
the culture media [10,24]). However, the report does not
refer to secreted proteins or the production of proteins
originating from sources other than bacteria. This hyper-
inducible expression vector can be further improved to
enable protein secretion and can be used to express higher
eukaryotic proteins. This vector may also enable rapid
progress in genome mining and the production of natu-
ral-product gene clusters such as those identified for
enediyne antibiotics [25].
An increasing number of studies over the past years have
reported Streptomyces as an ideal host for the production
of secreted proteins. Signal peptides are an important fac-
tor for improving the efficiency of secreted protein pro-
duction, and are extensively studied via mutagenic
approaches [26]. Several Streptomyces  secretion systems
have successfully produced eukaryotic proteins [27-29].
The soluble form of human CD4 was efficiently produced
using S. lividans as a host cell. Over 300 mg of protein was
produced per liter culture by using pLTI-CD4 containing
S. longisporus serine protease inhibitor gene promoter and
secretion signals [27].
Rhodococcus species
In Rhodococcus, several cloning vectors have been devel-
oped since the first report on E. coli-Rhodococcus shuttle
vector [30], and recently, versatile expression vectors have
been constructed [11,12]. The expression levels of pro-
teins from these vectors are not as high as that from the
expression system in E. coli (a maximum of 10 mg of pro-
tein per liter of culture media). However, in Rhodococcus,
proteins can be expressed over a wide range of tempera-
tures – from 4°C to 35°C [11,12] – because some Rhodo-
coccus  cells are psychrotrophic. When the thiostrepton
inducible tipA promoter was used, several milligrams of
mouse protein per liter of culture media could be
expressed even at 4°C [11].
Most of the recombinant protein expression systems
established until recently can only be used within the
range of 10°C to 37°C. For example, E. coli is a mes-
ophilic bacterium that grows at temperatures ranging
from 18°C to 37°C, and recombinant protein expression
has been carried out in a similar range of growth temper-
atures [31]. It is commonly known that a lower tempera-
ture is often more preferable for the production of
recombinant proteins [32]. Some mouse proteins that
could not be expressed in E. coli could be expressed in Rho-
dococcus at 4°C [11]. The expression at lower temperatures
is expected to be effective in producing proteins that dam-
age the host cell, because enzymatic activities of such pro-
teins can be suppressed.
In the case of R. erythropolis, the mycolic acid composition
of the host cells makes it difficult to disrupt the cell walls
and necessitates an approach for the modification of the
host cells to simplify recombinant-protein extraction pro-
cedures [33]. The authors reported lysozyme-sensitive
mutants that can be lysed by the addition of 12.5 µg ml-1
lysozyme, while the wild type is resistant to over 1 mg ml-
1  lysozyme.  Rhodococcus  spp. are tolerant to various
organic solvents and toxic chemicals. A highly efficient
bioconversion process can be achieved by the combina-
tion of the expression system and this characteristic fea-
ture of Rhodococcus spp.
Corynebacterium and Mycobacterium species
Corynebacterium and Mycobacterium spp. are phylogeneti-
cally closely related to Rhodococcus spp. [34]. C. glutami-
cum is used for the industrial production of L-glutamate,
while C. diphtheriae is the causative agent of diphtheria
[35]. Among the Mycobacterium  spp., the fast-growing
non-pathogenic M. smegmatis is widely used as a model
species [36]. Microorganisms such as M. tuberculosis and
M. leprae, which are highly virulent human pathogens, are
also well characterized species [8]. Spratt et al. identified
strong expression promoters and demonstrated that one
of them enabled the production of approximately 125 µg
protein per milligram cell lysate [20]. The techniques
developed by the authors for identifying the above men-
tioned novel promoters may be useful, although the tech-
nique is only applicable to constitutive promoters. As
shown in Table 1, some other expression vectors in these
species are used to express homologous and/or heterolo-
gous proteins.
Conclusion
When expressing recombinant proteins, it is often recom-
mended to use host cells that are phylogeneticaly closelyMicrobial Cell Factories 2005, 4:7 http://www.microbialcellfactories.com/content/4/1/7
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(ideally, identical) related to the origin of the protein of
interest. This is due to the similarity in frequency of codon
usage, compatibility with machineries of translation and
molecular chaperones, and/or redox states of the cells.
Hence, when expressing higher eukaryotic proteins, in
principle, using higher eukaryotes as hosts is ideal but it
often results in low yields, and furthermore, is expensive
and time consuming.
The host-vector systems of actinomycetes are suitable for
expressing proteins of actinomycetes and proteins from
closely related organisms as well as from higher eukaryo-
tes. However, further development of host-vector system
in actinomycetes is required, particularly with respect to
the modification of host cells. This includes improvement
in stability and easy maintenance of foreign genes (e.g.,
integration of plasmids), removing host proteins that
hamper production (e.g., knock-out of proteases) either at
the gene level or during the extraction of proteins.
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